Tag: Covid-19 disease
AstraZeneca’s Covid-19 vaccine shows robust responses in Phase I and II...
Interim results from the ongoing Phase I and II COV001 trial, led by Oxford University, showed that AstraZeneca's AZD1222 was tolerated and generated robust...
AstraZeneca to supply 400 million doses of vaccine at no profit
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400...